Loading...
XSHE
000963
Market cap10bUSD
Dec 05, Last price  
42.13CNY
1D
-0.59%
1Q
-3.44%
Jan 2017
75.40%
IPO
23.91%
Name

Huadong Medicine Co Ltd

Chart & Performance

D1W1MN
XSHE:000963 chart
P/E
21.04
P/S
1.76
EPS
2.00
Div Yield, %
2.21%
Shrs. gr., 5y
0.04%
Rev. gr., 5y
3.41%
Revenues
41.91b
+3.75%
3,484,232,5893,942,455,3214,853,413,4206,016,486,1417,824,872,1648,971,836,50911,131,372,42214,579,230,37416,717,986,44618,947,379,09421,727,383,49425,379,667,50227,831,823,14830,663,374,32635,445,698,21633,683,058,75934,563,301,23337,714,587,45840,391,192,25141,905,707,385
Net income
3.51b
+23.72%
67,313,91883,351,285173,160,209168,609,741378,421,189317,306,761381,484,999469,927,239574,975,854756,669,4191,096,912,4321,446,591,6981,779,506,0612,267,229,1742,813,118,7022,819,861,2032,301,631,3472,499,214,3592,838,860,5423,512,104,678
CFO
3.75b
-4.59%
203,330,80857,380,441265,790,560344,689,663567,939,912016,123,655642,729,226476,977,321740,854,724658,536,2561,346,962,8071,661,118,6632,039,496,0832,001,698,1703,411,447,7473,169,757,8672,381,852,6683,929,216,7063,748,928,882
Dividend
Sep 20, 20240.35 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Huadong Medicine Co., Ltd produces and sells various pharmaceutical products in China. It offers Chinese patent drugs, immunosuppressive agents, endocrine drugs, digestive system drugs, antineoplastic drugs, cardiovascular drugs, medical cosmetology, and antibiotic drugs, as well as medical equipment. The company's products include gastrointestinal agents, APIs, and other products. It also engages in the production and management of traditional Chinese and western raw medicines and preparations, and health care products; wholesale of TCM materials, TCM decoction pieces, chemical preparations, etc.; warehousing and storage business; and research, development, production, and sale of aesthetic medicine products. Huadong Medicine Co., Ltd was founded in 1993 and is headquartered in Hangzhou, China.
URL
https://www.eastchinapharm.com/
IPO date
Jan 27, 2000
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT